Exosens (LSE:0EXO) EBITDA: €115.3 Mil (TTM As of Dec. 2025)


LSE:0EXO Exosens SA LSE:0EXO
46 GF Score
Price €21.00
! 3 Warning Signs
View Full Analysis

What is Exosens EBITDA?

Exosens LSE:0EXO 46 EBITDA is €115.3 Mil as of Dec. 2025. GuruFocus rates LSE:0EXO with a GF Score™ of 46/100. The stock has 3 warning signs investors should review.

Exosens's EBITDA for the six months ended in Dec. 2025 was €52.0 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €115.3 Mil.

During the past 12 months, the average EBITDA Growth Rate of Exosens was -15.50% per year. During the past 3 years, the average EBITDA Growth Rate was 32.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 6 years, the highest 3-Year average EBITDA Growth Rate of Exosens was 32.80% per year. The lowest was 27.30% per year. And the median was 30.05% per year.

Exosens's EBITDA per Share for the six months ended in Dec. 2025 was €1.03. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was €2.27.

During the past 12 months, the average EBITDA per Share Growth Rate of Exosens was -15.40% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 6 years, the highest 3-Year average EBITDA per Share Growth Rate of Exosens was 27.30% per year. The lowest was 12.00% per year. And the median was 19.65% per year.

Exosens  (LSE:0EXO) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Exosens EBITDA Related Terms


Exosens EBITDA Historical Data

* Premium members only.

The historical data trend for Exosens's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens EBITDA Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial -101.18 51.25 75.27 142.10 120.10

Exosens Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only 42.41 48.19 93.91 63.28 52.02

LSE:0EXO vs VRT, BE, NVT: EBITDA Comparison

For the Electrical Equipment & Parts subindustry, Exosens's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exosens EV-to-EBITDA vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Exosens's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Exosens's EV-to-EBITDA falls into.


LSE:0EXO
46GF Score
Exosens SA LSE:0EXO
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Exosens's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Exosens's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, Exosens's EBITDA was €120.1 Mil.

Exosens's EBITDA for the quarter that ended in Dec. 2025 is calculated as

Exosens's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, Exosens's EBITDA was €52.0 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €115.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of €115.3 Mil mean?
Exosens (LSE:0EXO) has a EBITDA of €115.3 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Exosens.
Is Exosens' EBITDA too high?
Exosens' current EBITDA is €115.3 Mil. Overall, Exosens has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' EBITDA compare to VRT and BE?
Exosens' EBITDA of €115.3 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for an Industrial Products company?
A good EBITDA depends on the Industrial Products industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Exosens. Exosens's current EBITDA is €115.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (LSE:0EXO) has a current EBITDA of €115.3 Mil. The current EBITDA is €115.3 Mil. Exosens' overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Exosens (LSE:0EXO), the current EBITDA is €115.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
46GF Score

Get the complete analysis for LSE:0EXO

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.00
Price